wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33388196-4CD6A617-DC39-4B0C-9538-FD3270716EBA
Q33388196-4CD6A617-DC39-4B0C-9538-FD3270716EBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33388196-4CD6A617-DC39-4B0C-9538-FD3270716EBA
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia
P2860
Q33388196-4CD6A617-DC39-4B0C-9538-FD3270716EBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33388196-4CD6A617-DC39-4B0C-9538-FD3270716EBA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2f137528059f11639731b31caa905b330fa3c65
P2860
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia